Medtech Talk

Renal Guard CEO Jim Dillon Discusses Spin Out of High Profile Reprieve Cardiovascular

10.15.2018 - By HealthegyPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Jim Dillon, president and CEO of Renal Guard, talks about the company’s decision to create Reprieve Cardiovascular, a start-up focusing on heart failure. Reprieve raised $7 million from outside investors, including Abiomed, and counts Serial Entrepreneur Howard Levin as chief medical officer.

More episodes from Medtech Talk